Assessment of Patient-centered Outcomes (PROs) in Inflammatory Bowel Disease (IBD): a Multicenter Survey Preceding a Cross-disciplinary (functional) Consensus

Overview

Journal Health Qual Life Outcomes

Publisher Biomed Central

Specialty Public Health

Date 2020 Jul 22

PMID 32690091

Citations 4

Authors

Xiaohan Yan

Yuqi Qiao

Jinglu Tong

Ren Mao

Jie Liang

Cuicui Lv

Yueying Chen

Yiyan Wang

Jun Shen

Affiliations

Soon will be listed here.

Abstract

Background: With a shift in the healthcare paradigm towards a more patient-centered approach, data on inflammatory bowel disease (IBD) needs to be further explored. This study aimed to determine patient perspectives on the effect of IBD and features of patients with lower satisfaction level and compare patient and physician perception of IBD-related Quality of Care (QoC).

Methods: A previously developed pre-standardised set of questions regarding patient-centered outcome (PRO) measures for IBD, comprising 36 items, was administered in five centers, and a concomitant questionnaire for specialised physicians was adapted and administered.

Results: Overall, 1005 patients with IBD met the inclusion criteria. Sixty-five questionnaires were administered to specialised physicians. Both patients and physicians perceived the IBD-related QoC as being satisfactory. Furthermore, this study revealed areas of shortcomings where it comes to patient perceptions. Female sex and the presence of negatively impacting disease characteristics (presence of significant pain or discomfort, lack of energy, feeling fatigued most of the time, experiencing anxiety or depression in the last 2 weeks) were associated with lower satisfaction levels.

Conclusions: Our findings can be used in establishing strategies aimed at improving patient QoC and defining strategic priorities. These data can aid in improving the communication of the pressing needs of IBD patients, to both the public payers and health authorities.

Citing Articles

Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.

Youssef M, Hossein-Javaheri N, Hoxha T, Mallouk C, Tandon P J Crohns Colitis. 2024; 18(9):1486-1504.

PMID: 38647194 PMC: 11369077. DOI: 10.1093/ecco-jcc/jjae057.

Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review.

Lungaro L, Costanzini A, Manza F, Barbalinardo M, Gentili D, Guarino M J Pers Med. 2023; 13(2).

PMID: 36836400 PMC: 9958616. DOI: 10.3390/jpm13020165.

Systematic Review and Meta-analysis on the Incidence, Prevalence and Determinants of Discomfort in Inflammatory Bowel Disease.

Nistor O, Godfrey C, Ross-White A, Wilson R J Can Assoc Gastroenterol. 2022; 5(2):96-97.

PMID: 35368319 PMC: 8972280. DOI: 10.1093/jcag/gwab043.

A New Preparation Method for Peroral Endoscopic Myotomy in Patients with Achalasia Can Effectively Reduce the Esophageal Residual Contents: A Comparative Retrospective Study.

Zhang Z, Yan X, Duan B, Leng Z, Zhang H, Li J Gastroenterol Res Pract. 2022; 2022:6953166.

PMID: 35154312 PMC: 8831038. DOI: 10.1155/2022/6953166.

References

Larsson S, Lawyer P, Garellick G, Lindahl B, Lundstrom M . Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value. Health Aff (Millwood). 2011; 31(1):220-7. DOI: 10.1377/hlthaff.2011.0762. View

Kim A, Roberts C, Feagan B, Banerjee R, Bemelman W, Bodger K . Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus. J Crohns Colitis. 2017; 12(4):408-418. DOI: 10.1093/ecco-jcc/jjx161. View

Siegel C, Melmed G, Ullman T . Improving quality of care in IBD: a STEEEP challenge. Inflamm Bowel Dis. 2009; 16(1):134-6. DOI: 10.1002/ibd.21024. View

McNamara R, Spatz E, Kelley T, Stowell C, Beltrame J, Heidenreich P . Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM). J Am Heart Assoc. 2015; 4(5). PMC: 4599409. DOI: 10.1161/JAHA.115.001767. View

Nurmi E, Haapamaki J, Paavilainen E, Rantanen A, Hillila M, Arkkila P . The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol. 2012; 48(1):51-7. DOI: 10.3109/00365521.2012.685750. View

Soares J, Marinho A, Fernandes D, Goncalves B, Camila-Dias C, Goncalves R . Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling. Eur J Gastroenterol Hepatol. 2015; 27(8):941-50. DOI: 10.1097/MEG.0000000000000385. View

Panes J, OConnor M, Peyrin-Biroulet L, Irving P, Petersson J, Colombel J . Improving quality of care in inflammatory bowel disease: what changes can be made today?. J Crohns Colitis. 2014; 8(9):919-26. DOI: 10.1016/j.crohns.2014.02.022. View

Molander P, Jussila A, Toivonen T, Makkeli P, Alho A, Kolho K . The impacts of an inflammatory bowel disease nurse specialist on the quality of care and costs in Finland. Scand J Gastroenterol. 2019; 53(12):1463-1468. DOI: 10.1080/00365521.2018.1541477. View

Vasudevan A, Arachchi A, van Langenberg D . Assessing patient satisfaction in inflammatory bowel disease using the QUOTE-IBD survey: a small step for clinicians, a potentially large step for improving quality of care. J Crohns Colitis. 2013; 7(9):e367-74. DOI: 10.1016/j.crohns.2013.02.012. View

10.

Lonnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L . IBD and health-related quality of life -- discovering the true impact. J Crohns Colitis. 2014; 8(10):1281-6. DOI: 10.1016/j.crohns.2014.03.005. View

11.

. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006; 4:79. PMC: 1629006. DOI: 10.1186/1477-7525-4-79. View

12.

Burisch J, Jess T, Martinato M, Lakatos P . The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013; 7(4):322-37. DOI: 10.1016/j.crohns.2013.01.010. View

13.

Hauser G, Tkalcic M, Stimac D, Milic S, Mijandrusic Sincic B . Gender related differences in quality of life and affective status in patients with inflammatory bowel disease. Coll Antropol. 2012; 35 Suppl 2:203-7. View

14.

Pittet V, Vaucher C, Froehlich F, Burnand B, Michetti P, Maillard M . Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator. PLoS One. 2017; 12(2):e0171864. PMC: 5302448. DOI: 10.1371/journal.pone.0171864. View

15.

Porter M . A strategy for health care reform--toward a value-based system. N Engl J Med. 2009; 361(2):109-12. DOI: 10.1056/NEJMp0904131. View

16.

Donabedian A . Evaluating the quality of medical care. 1966. Milbank Q. 2005; 83(4):691-729. PMC: 2690293. DOI: 10.1111/j.1468-0009.2005.00397.x. View

17.

Prisco V, Iannaccone T . [Inflammatory bowel disease and quality of life: psychopathological variants.]. Recenti Prog Med. 2017; 108(2):83-89. DOI: 10.1701/2636.27099. View

18.

Jelsness-Jorgensen L, Bernklev T, Hovde O, Berset I, Huppertz-Hauss G, Moum B . Patients' perceptions of quality of care and follow-up in inflammatory bowel disease. Scand J Gastroenterol. 2015; 51(4):434-41. DOI: 10.3109/00365521.2015.1102319. View

19.

Gonczi L, Kurti Z, Verdon C, Reinglas J, Kohen R, Morin I . Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre. J Crohns Colitis. 2019; 13(9):1138-1147. DOI: 10.1093/ecco-jcc/jjz035. View

20.

Williams J, Alam M, Alrubaiy L, Arnott I, Clement C, Cohen D . Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016; 1(1):15-24. PMC: 4994668. DOI: 10.1016/S2468-1253(16)30003-6. View